BriaCell Therapeutics Corp.: Form 40-F for the period ended Jul 31, 2021
Filed with the SEC on Oct 29, 2021 and accepted by EDGAR at Oct 29, 2021, 16:15 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-21-026729. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.